Concordance of two polymerase chain reaction–based blood group genotyping platforms for patients with sickle cell disease
By: C.A. Sheppard, N.L. Bolen, G. Meny, M. Kalvelage and G. Ochoa-Garay
Paid access
|Jan 2020Authors
C.A. Sheppard
Gold Standard Laboratory Consulting Group, LLC, and Department of Pathology, University of Virginia, Charlottesville, Virginia
N.L. Bolen
Immunohematology Reference Laboratory, ITxM Diagnostics, Richmond, VA
G. Meny
Medical Affairs Diagnostic, Grifols Diagnostic Solutions, San Marcos, TX
G. Ochoa-Garay
Immunohematology Center, Grifols Diagnostic Solutions, San Marcos, TX
DOI: https://doi.org/10.21307/immunohematology-2020-050 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 123 - 128
Published on: Jan 1, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2020 C.A. Sheppard, N.L. Bolen, G. Meny, M. Kalvelage, G. Ochoa-Garay, published by American National Red Cross
This work is licensed under the Creative Commons License.